Goldman sachs initiates cue health at buy rating with $19 price target If you are looking for stocks with good return, cue health inc can be a profitable investment option.
(hlth) has a beta value of 0, and an average true range (atr) of 1.37.
Cue health stock price target. The latest price target for cue health ( nasdaq: (hlth) stock quote, history, news and other vital information to help you with your stock trading and investing. According to the issued ratings of 3 analysts in the last year, the consensus rating for cue biopharma stock is buy based on the current 3 buy ratings for cue.
The ipo raised $200 million for the company and gives it a valuation of $2.3 billion. Find the latest cue health inc. Hlth updated stock price target summary.
Looking to buy cue health stock? The successful prediction of cue health's future price could yield a significant profit. Cue health announces pricing of initial public offering.
Is a healthcare technology company which. (hlth) stock price quote with breaking news, financials, statistics, charts and more. The average cue health stock price prediction forecasts a potential downside of n/a from the current hlth share price of $9.90.
Cue health stock price prediction is an act of determining the future value of cue health shares using few different conventional methods such as eps estimation, analyst consensus, or fundamental intrinsic valuation. Cue health (nasdaq:hlth) price target and consensus rating how marketbeat calculates price target and consensus rating 9, 2020 at 8:58 a.m.
On average, wall street analysts predict that. According to analyst projections, hlth’s forecast low is $12.00 with $19.00 as the target high. Goldman sachs initiates cue health at buy rating with $19 price target
Btig has initiated cue health (hlth +5.5%) with a buy rating, as the company is one of the fastest growing diagnostic testing companies we've ever seen. the firm has an $18 price. (nasdaq:hlth) has seen 1.04 million shares traded in the last trading session. Cue biopharma started at buy with $21 stock price target at stifel nicolaus apr.
Get the latest cue health stock price and detailed information including hlth news, historical charts and realtime prices. Learn more on cue's analyst rating history Btig initiates cue health with a buy rating, citing fast growth.
Baird has the lowest price target set, forecasting a price of $28.00 for cue biopharma in the next year. Cue health's share price could stay at $15.00 by oct 19, 2022. What analysts think hlth will be worth.
Et by tomi kilgore cue biopharma started at outperform with $27 stock price target at. How high can cue health (hlth) stock go? The analyst firm set a price.
Hlth) was reported by morgan stanley on october 19, 2021. Dec 3, 2021 4:00 p.m. Berenberg bank has the highest price target set, predicting cue will reach $30.00 in the next twelve months.
Analyst ratings, historical stock prices, earnings estimates & actuals. Hlth), a health technology company, today announced the pricing of its initial public offering of 12,500,000 shares of its common stock at a public offering price of $16.00 per share, for gross proceeds of $200.00. The consensus price target for the stock as assigned by wall street analysts is $15.75, meaning bulls need an upside of 43.37% from its current market value.
Get the stock price and latest news for hlth and start trading today with zero commissions.
